Ad-SGE-REIC + Anti-tumor Agent
Liver Cancer
Preclinical/ResearchPatent Filed
Key Facts
About Momotaro-Gene
A Japanese biotech developing REIC/Dkk-3 gene therapy for solid tumors, with a lead program in malignant glioma.
View full company profileTherapeutic Areas
Other Liver Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| CY-101 | Cytovation | Phase 1 |
| SA-033 | Double Bond Pharmaceutical | Pre-clinical |
| PRDM2 Target | ARIZ Precision Medicine | Discovery |
| PanGIA Liver | PanGIA Biotech | Pre-clinical |
| Alpha DaRT | Alpha Tau Medical | Not Specified |